Electra Therapeutics

Electra Therapeutics develops antibody therapies targeting the SIRP receptor to treat immunology and cancer, specifically life-threatening sHLH.
Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Series B
Initial Investment Year
2022